Tag Archives: TPIV

TPIV Looks To Shake Off The Dip And Bounce Back!

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

After an exciting end to last week, and rather solid start to this week, we saw TPIV consolidate considerably today, closing down by more than -10% at .648 with $1.3M exchanging hands.

We have seen this from TPIV (TapImmune, Inc.) in the past, and believe it is another short lived drop in the stock before it carries onward and upward towards it’s 52 week highs of $1.70.

The company is looking to obtain Orphan Drug Designation (ODD) and FDA Fast Track Accelerated Approval for their breakthrough cancer vaccine by year’s end, news which we believe would warrant a higher move in the company’s shares.

That is why we are bringing TPIV to our members attention now, and have been riding this evolving money-train over the past couple months, anticipating a much bigger move from current levels.

Keep TPIV on top of your watch list for this week!

Happy Trading!

Sign up-> NOW <-To Join Our E-mail List!

Happy Trading!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

We continue trade up to 100,000 shares of TPIV which we have purchased on the open market with our own money. We have no communication with the company nor any affiliates. We may add to this position or sell it entirely at any time. We have no position at this time.

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

TPIV Continues Along It’s Upward Path!

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

We hope all of you have had a delightful weekend. It would be hard not to considering how TPIV closed the week out, closing up nearly 20% Friday, above major resistance, given our ‘table-pounding’ highlights of the company over the past couple months.

TPIV (TapImmune, Inc.) finally made it’s way past .70, reaching a high of .749 Friday, closing above that level for the first time in several months, and could be on it’s way to continuing higher from here.

As we have noted in our previous blog posts, the stock reached a high of $1.70 earlier this year, and we believe it has the potential to do that again, maybe more if the efficacy of their vaccine proves to be as positive as anticipated.

Keep TPIV on top of your watch list for this week!

Congratulations to those who have done their research on TPIV and are already ahead of the game, for those of you who haven’t we suggest catching up and researching what could be one of the most exciting small cap companies.

Happy Trading!

Sign up-> NOW <-To Join Our E-mail List!

Happy Trading!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

We continue trade up to 20,000 shares of TPIV which we have purchased on the open market with our own money. We have no communication with the company nor any affiliates. We may add to this position or sell it entirely at any time. We have no position at this time.

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

Stocks In Focus For Thursday 11/05/15 – MEIP TPIV

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

MEIP (MEI Pharma, Inc.) had a very positive day today, closing up 14.21%, with it’s highest volume traded in months of more than 3.1 million shares, and managed to close above $2.00 for the first time in about 6 months. All of these positives in the stock could lead to a further breakout in price leading into the ASH meeting on December 7th; read and follow our previous blog post on the stock, HERE.

We are never shy of taking profit when we believe we might be able to buy cheaper, and that may be something to consider tomorrow if it wasn’t considered today.

TPIV (TapImmune, Inc.) has also been a point of focus for us recently, with multiple blog posts outlining our bullish thesis for the stock, and over the past week the company filed to being Phase II trials for their Folate Receptor Alpha vaccine. You can view that information, HERE.

This only reaffirms our views towards the stock, and encourages us to look to continue to consider adding to our already established positions.

Happy Trading!

Sign up-> NOW <-To Join Our E-mail List!

Happy Trading!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

We continue trade up to 20,000 shares of TPIV which we have purchased on the open market with our own money. We have no communication with the company nor any affiliates. We may add to this position or sell it entirely at any time.

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

MEIP Is A Small-Cap With Big Potential Into December!

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

Our week with TPIV (TapImmune, Inc.) started where we left off, closing even on the day at .61 with over 250K shares traded, continuing to churn in this range until deciding what it really wants to do (which we believe is to go up in a big way, again).

While TPIV continues to warm up, we have our eyes on other prospects operating in a similar space, more specifically MEIP (MEI Pharma, Inc.) which trades on the NASDAQ and could have a very exciting end to 2015.

MEIP (MEI Pharma, Inc.) plans to unveil Phase II clinical results for their drug, Pracinostat, which is being developed for advanced hematologic diseases such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), at the 2015 American Society of Hematology (ASH) Program Committee on December 7th. 

It should be noted that last year at this time MEIP traded up near $8 a share, but after bad news in March of this year that a different Phase II trial failed to reach it’s primary end point, the share price dropped from $6 to less than $2 overnight.

Following today’s price action, we are going to be looking to establish a position near the $1.65 range, maybe higher or lower depending on how the price sustains itself over the next few sessions.

Keep MEIP on top of your radar into December, as we believe results could be much better this time around!

Happy Trading!

Sign up-> NOW <-To Join Our E-mail List!

Happy Trading!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

We have no communication with any of the company’s mentioned nor any affiliates. We hold no position in MEIP or TPIV at the current time, but plan to trade and/or establish a position in both stocks over the short term and will update our blog accordingly.

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

Keep TPIV On Watch Tomorrow – New Pick Tuesday!

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

We hope all of you have enjoyed a nice weekend.

Our profiled pick TPIV (TapImmune, Inc.) had a rather lackluster week last week, closing even on the week with a range of .525-.65, but continues to hold well during an accumulation phase, as we look forward to the mid to longer term potential. The stock made a move up to $1.70 earlier this year, during earlier stage clinical trials, and we would think as the company further advances in these trials that the stock price would (hopefully) reflect.

Keep the stock on top of your watch list, and look for a new pick coming as early as tomorrow, as we look to feature our first NASDAQ listed small-cap pick, also biotech related, which also turn into a big winner as we move towards the end of the year.

 

Happy Trading!

Sign up-> NOW <-To Join Our E-mail List!

Happy Trading!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

We continue trade up to 20,000 shares of TPIV which we have purchased on the open market with our own money. We have no communication with the company nor any affiliates. We may add to this position or sell it entirely at any time.

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

TPIV Is Back On Watch For Thursday!

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

Last night we didn’t get a chance to upload our full watch list, so we posted a quick list on our Twitter page, but that’s alright considering what we would’ve watched didn’t make earth shattering moves. That’s been the mantra for OTCs lately, and basically this entire year, as the “wild west” of small caps continues to look for a reason to gain real volume.

TPIV (TapImmune, Inc.) has weathered the storm, however, like many biotechs, trading up to a high of $1.70 this year following early results related to their breast cancer vaccine, which is now being funded in part by the U.S. Dept. of Defense. Read the full press release related to the DoD’s grant, HERE, and keep the stock on top of your speculative buy watch list as the company moves into later stage clinical trials and results are made available.

It is still our intention to release a full report/e-mail alert to our subscribers, but anyone who has followed us for any amount of time knows how important we feel timing is.

The time will come, and we will alert TPIV on a broader scale, but for now the stock is in an accumulation phase, which could mean even bigger gains for those who stick their neck out there and experiment early, but also presents greater risks.

Considering the stock closed at today’s high of .59, and is just a couple cents off this week’s high of .615, we could see this accumulation phase come to an end rather quickly over the short term.

Keep this stock on the tippity-top of your watch list!

Happy Trading!

Sign up-> NOW <-To Join Our E-mail List!

Happy Trading!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

We continue trade up to 20,000 shares of TPIV which we have purchased on the open market with our own money. We have no communication with the company nor any affiliates. We may add to this position or sell it entirely at any time.

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

Stocks In Focus For Monday 10/12/15 – MYEC EVTI TPIV

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

We hope all of you have enjoyed a nice weekend.

TPIV (TapImmune, Inc.) has been our main focus over the past few weeks, trading up from a range below .50 to a high of .70, and is settling in between near the .60 range now. Shares have seen increased support following the announcement of a grant received from the U.S. Dept. Of Defense totaling $13.3M to fund the company’s breast cancer vaccines Phase II clinical trial. Read the full press release, HERE, and continue to keep the stock on your watch list.

MYEC (MyECheck, Inc.) closed out last week up by more than 30%, following the announcement Thursday that the SEC had accepted the company’s Form 10 registration statement to become a fully reporting company. The stock traded more than 20 million shares last week, nearly 10 million of which traded on Friday alone. Look for this bullish action to potentially carry over into tomorrow and/or next week.

EVTI (Eventure Interactive, Inc.) had a positive finish to the week, closing up 25% with above average volume of 56.7 million shares traded, but continues to battle sellers that we pointed out last week at this time. Our blog post from last Sunday evening still applies, read HERE to follow our thoughts if you missed them and keep the stock on watch tomorrow just in case.

Happy Trading!

Sign up-> NOW <-To Join Our E-mail List!

Happy Trading!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

We continue trade up to 20,000 shares of TPIV which we have purchased on the open market with our own money. We have no communication with the company nor any affiliates. We may add to this position or sell it entirely at any time.

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

TPIV In Full Focus To End The Week!

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

TPIV (TapImmune, Inc.) had another solid trading day today, closing up nearly 5% with a slight bump up in volume compared to the past several days, as the company announced their plans to present at the Aegis Capital 2015 Growth Conference in Las Vegas this Friday, October 9th. Read the full press release, HERE.

Shares are up now 7.50% on the week, and as the range tightens between .60-.70, we see a breakout one way or the other over the short term. Ideally, that breakout would be a close above the .70 level rather than a test below .60.

Over the mid-long term, and the bigger picture here, we can see TPIV trading much higher (as it has already proven it can) as the news can hypothetically only get better should clinical results remain positive, and believe buyers on short term dips may be rewarded greatly over time.

Keep the stock on top of your watch list!

Happy Trading!

Sign up-> NOW <-To Join Our E-mail List!

Happy Trading!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

We continue trade up to 20,000 shares of TPIV which we have purchased on the open market with our own money. We have no communication with the company nor any affiliates. We may add to this position or sell it entirely at any time.

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

Stocks In Focus For Tuesday 10/06/15 – TPIV FARE

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

TPIV (TapImmune, Inc.) had a solid start to the week, grinding higher by more than 5% at the close of .631, and would have closed even higher had a handful of people not chose to wait to the last minute to sell their shares. We will maintain our bullish perspective on the company as progress continues to be reported over the next couple months, and will focus on resistance of .65 and .70 over the short term as far as trading is concerned.

Keep the stock on top of your mid-long term watch list.

FARE (World Moto, Inc.) shares soared today, following an announcement from the company an hour before the open stating that they have begun shipping and fulfilling purchase orders for their Moto-Meter product, closing up more than 238% on the day just off the session high. The stock opened the day at .0017 per share (above it’s previous close of .0013), and held that price as a low, climbing nearly the entire day up to a high of .0045 and closing at .0044. Watch for positive momentum to carry over into tomorrow, and with a strong open, a dip shortly after things kick-off may warrant a buy.

Keep the stock on your watch list for Tuesday.

Happy Trading!

Sign up-> NOW <-To Join Our E-mail List!

Happy Trading!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

We continue hold/trade up to 20,000 shares of TPIV which we have purchased on the open market with our own money. We have no communication with the company nor any affiliates. We may add to this position or sell it entirely at any time.

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

Stocks To Watch For Monday 10/05/15 – TPIV & EVTI

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

We hope all of you have enjoyed a nice weekend. As we move into the end of the year, and temperatures begin to cool, we fully expect the market to heat up. The broader markets showed impressive strength Friday, which could be a hint of what we could expect moving forward from here.

Our mid-long term pick TPIV (TapImmune, Inc.) had an overall quiet week last week, but quiet is better than tumultuous, as shares continued to hold higher support and accumulation continues to take place. The company is working directly with the Mayo Clinic, funded by a $13.3M U.S. Department of Defense grant, to potentially commercialize a vaccine for the most reoccurring form of breast cancer.

It is our own personal belief that a grant of this magnitude could be a key clue as to what the vaccine’s true potential might be, and therefore we have formulated a bullish opinion on the company and started accumulating our own position in the stock.

We will update all of you as the story develops and progress continues to be reported.

EVTI (Eventure Interactive, Inc.) which is also a stock/company we have featured multiple times recently, was dragged back towards it’s lows on Friday only to be met with heavy support and buying pressure, closing at it’s high of .0022 up nearly 30% on the day.

The stock has dealt with a swarm of sellers, which have been present on the stock nearly every day since our coverage, but have more recently become increasingly aggressive. We aren’t totally convinced they are through selling, but if so (as potentially indicated by Friday’s record 120 million share volume day) it could be one to watch for a much bigger bounce.

Keep both of these companies on your watch list for Monday, and enjoy the rest of your weekend!

Sign up-> NOW <-To Join Our E-mail List!

Happy Trading!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

We hold up to 20,000 shares of TPIV which we have purchased on the open market with our own money. We have no communication with the company nor any affiliates. We may add to this position or sell it entirely at any time.

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.